FDA Adverse Event Injury Summary report: N

TALENT CAPTIVIA STENT GRAFT SYSTEM

MDR report key: 2210570 · Received August 10, 2011

Report

Report Number
2953200-2011-01415
Event Type
Injury
Date Received
August 10, 2011
Date of Event
July 10, 2011
Report Date
July 11, 2011
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
MIH
PMA / PMN Number
P070007
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: ENDOLEAK. RESULTS/CONCLUSIONS: (UNK CAUSE OF ENDOLEAK).

Description of Event or Problem · 1

A TALENT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PT FOR THE ENDOVASCULAR TREATMENT OF A LEAKING PSEUDOANEURYSM, WHICH HAD AN EXPANDING HEMATOMA. THE THORACIC AORTA HAD APPROXIMATELY 5-6 MM SIZE DIFFERENCE FROM THE FLOW LUMEN TO THE OUTER MEASUREMENT OF THE HEMATOMA. THE ILIAC VESSELS WERE STRAIGHT AND UNREMARKABLE. IT WAS REPORTED TWO TALENT CAPTIVIA STENT GRAFTS, A 38X38X199 (MFR REPORT# 2953200-2011-01415) AND A 36X36X199 (MFR REPORT # 2953200-2011-01416), WERE IMPLANTED FROM THE LEFT SUBCLAVIAN ARTERY DOWN TO 2 CM ABOVE THE CELIAC ARTERY. ON THE FINAL ANGIOGRAM, NO ENDOLEAK WAS EVIDENT; HOWEVER, AT A FOLLOW-UP CT APPROXIMATELY 2 WEEKS POST-PROCEDURE, A DISTAL TYPE I ENDOLEAK WAS SEEN. THE PHYSICIAN ELECTED TO INTERVENE BY PLACING A DISTAL EXTENSION, WHICH LANDED RIGHT AT THE CELIAC ARTERY. THE FINAL ANGIOGRAM SHOWED THE CELIAC FILLING AND THAT THE ENDOLEAK WAS RESOLVED. HOWEVER, SEVERAL DAYS AFTER, A CT WAS PERFORMED AND DEMONSTRATED AN UNK ENDOLEAK, WHICH MIGHT HAVE BEEN A TYPE II ENDOLEAK OR A JUNCTIONAL TYPE III ENDOLEAK BETWEEN THE TWO INITIAL STENT GRAFTS. THE PHYSICIAN DECIDED NOT TO PERFORM ANY INTERVENTION BUT WILL MONITOR THE PT. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PT IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TALENT CAPTIVIA STENT GRAFT SYSTEM MIH MEDTRONIC CARDIOVASCULAR GALWAY NA V00565887

Patients

Seq Age Sex Outcome Treatment
1 68 YR Required Intervention